Patents by Inventor Andreas SCHLICKER

Andreas SCHLICKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease
    Patent number: 11976334
    Abstract: The present invention covers 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine (in the following called “Compound A”), an inhibitor of ATR kinase, for use in a method of treating a hyper-proliferative disease in a subject.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: May 7, 2024
    Assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft
    Inventors: Antje Margret Wengner, Gerhard Siemeister, Bernard Händler, Sven Golfier, Andreas Schlicker, Li Liu
  • INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-PROLIFERATIVE DISEASE
    Publication number: 20210404012
    Abstract: The present invention covers 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine (in the following called “Compound A”), an inhibitor of ATR kinase, for use in a method of treating a hyper-proliferative disease in a subject.
    Type: Application
    Filed: February 1, 2021
    Publication date: December 30, 2021
    Applicants: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft
    Inventors: Antje Margret WENGNER, Gerhard SIEMEISTER, Bernard HÄNDLER, Sven GOLFIER, Andreas SCHLICKER, Li LIU
  • MEDICAL DEVICE COMPRISING A TOOTH PROTECTIVE DEVICE FOR ORAL INTUBATION PROCEDURES
    Publication number: 20200205650
    Abstract: The Invention relates to a medical device (1) for oral procedures, particularly for use in oral intubation and fixation procedures, comprising at least one protective device (2) for teeth, the protective device (2) comprising the a rigid support component (3), and at least one push button (4), arranged at the support component (3), wherein each of the at least one the push button (4) comprises a rigid surface (42) that is facing towards the teeth, when the medical device (1) is applied orally, wherein the support component (3) is configured such that each of the at least one push button (4) is displaceable separately relative to the support component (3) between a first position and a second position.
    Type: Application
    Filed: July 2, 2018
    Publication date: July 2, 2020
    Applicant: UNIVERSITÄT ZÜRICH
    Inventors: Andreas SCHLICKER, Carsten SCHRÖDER, Sascha WEIDNER
  • AN INHIBITOR OF ATR KINASE FOR USE IN A METHOD OF TREATING A HYPER-PROLIFERATIVE DISEASE
    Publication number: 20200063212
    Abstract: The present invention covers 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyra-zol-5-yl)-1,7-naphthyridine (in the following called “Compound A”), an inhibitor of ATR kinase, for use in a method of treating a hyper-proliferative disease in a subject.
    Type: Application
    Filed: February 22, 2018
    Publication date: February 27, 2020
    Applicants: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft
    Inventors: Antje Margret WENGNER, Gerhard SIEMEISTER, Bernard HÄNDLER, Sven GOLFIER, Andreas SCHLICKER, Li LIU